NERV Q2 2021 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena

NERVMinerva Neurosciences, Inc.

$53M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$9M

Net Income

-$11M

EPS (Diluted)

$-1.98

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$105M

Total Liabilities

$69M

Stockholders' Equity

$36M

Cash & Equivalents

$74M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$41M	-100.0%
Gross Profit	$0	$41M	-100.0%
Operating Income	-$9M	$30M	-130.4%
Net Income	-$11M	$30M	-135.9%